<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="jbc"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC3636881/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Aspirin Hydrolysis in Plasma Is a Variable Function of Butyrylcholinesterase and Platelet-activating Factor Acetylhydrolase 1b2 (PAFAH1b2)</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636881/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="The Journal of Biological Chemistry"><meta name="citation_title" content="Aspirin Hydrolysis in Plasma Is a Variable Function of Butyrylcholinesterase and Platelet-activating Factor Acetylhydrolase 1b2 (PAFAH1b2)"><meta name="citation_authors" content="Gang Zhou, Gopal K. Marathe, Jaana Hartiala, Stanley L. Hazen, Hooman Allayee, W. H. Wilson Tang, Thomas M. McIntyre"><meta name="citation_date" content="26 April 2013"><meta name="citation_issue" content="17"><meta name="citation_volume" content="288"><meta name="citation_firstpage" content="11940"><meta name="citation_doi" content="10.1074/jbc.M112.427674"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3636881/?report=abstract"><meta name="citation_pmid" content="23508960"><meta name="DC.Title" content="Aspirin Hydrolysis in Plasma Is a Variable Function of Butyrylcholinesterase and Platelet-activating Factor Acetylhydrolase 1b2 (PAFAH1b2)"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="American Society for Biochemistry and Molecular Biology"><meta name="DC.Contributor" content="Gang Zhou"><meta name="DC.Contributor" content="Gopal K. Marathe"><meta name="DC.Contributor" content="Jaana Hartiala"><meta name="DC.Contributor" content="Stanley L. Hazen"><meta name="DC.Contributor" content="Hooman Allayee"><meta name="DC.Contributor" content="W. H. Wilson Tang"><meta name="DC.Contributor" content="Thomas M. McIntyre"><meta name="DC.Date" content="2013 Apr 26"><meta name="DC.Identifier" content="10.1074/jbc.M112.427674"><meta name="DC.Language" content="en"><meta property="og:title" content="Aspirin Hydrolysis in Plasma Is a Variable Function of Butyrylcholinesterase and Platelet-activating Factor Acetylhydrolase 1b2 (PAFAH1b2)"><meta property="og:type" content="article"><meta property="og:description" content="Aspirin is rapidly hydrolyzed within erythrocytes by a heterodimer of PAFAH1b2/PAFAH1b3 but also in plasma by an unidentified activity. Hydrolysis in both compartments was variable, with a 12-fold variation in plasma among 2226 Cleveland Clinic GeneBank ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636881/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-jbc.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC3636881/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC3636881/pdf/zbc11940.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE888A1DDD5561410000000004AC0313.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-3"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3636881%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/567/">J Biol Chem</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/222308/">v.288(17); 2013 Apr 26</a></li><li class="accid">PMC3636881</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-jbc.png" alt="Logo of jbc" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,0,500,75" alt="The Journal of Biological Chemistry" title="The Journal of Biological Chemistry" href="http://www.jbc.org" ref="reftype=publisher&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">J Biol Chem</a></span>. 2013 Apr 26; 288(17): 11940–11948. </span></div><div><span class="fm-vol-iss-date">Published online 2013 Mar 18. </span>  <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1074%2Fjbc.M112.427674" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1074/jbc.M112.427674</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3636881</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/23508960">23508960</a></div></div></div></div><h1 class="content-title">Aspirin Hydrolysis in Plasma Is a Variable Function of Butyrylcholinesterase and Platelet-activating Factor Acetylhydrolase 1b2 (PAFAH1b2)<sup><a href="#FN1" rid="FN1" class=" fn">*</a></sup></h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Zhou%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23508960" class="affpopup" co-rid="_co_idm139867486128048" co-class="co-affbox">Gang Zhou</a>,<sup>‡</sup> <a href="/pubmed/?term=Marathe%20GK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23508960" class="affpopup" co-rid="_co_idm139867446764160" co-class="co-affbox">Gopal K. Marathe</a>,<sup>‡</sup> <a href="/pubmed/?term=Hartiala%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23508960" class="affpopup" co-rid="_co_idm139867443868784" co-class="co-affbox">Jaana Hartiala</a>,<sup>§</sup> <a href="/pubmed/?term=Hazen%20SL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23508960" class="affpopup" co-rid="_co_idm139867447905456" co-class="co-affbox">Stanley L. Hazen</a>,<sup>‡</sup> <a href="/pubmed/?term=Allayee%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23508960" class="affpopup" co-rid="_co_idm139867447903344" co-class="co-affbox">Hooman Allayee</a>,<sup>§</sup> <a href="/pubmed/?term=Tang%20WH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23508960" class="affpopup" co-rid="_co_idm139867446807328" co-class="co-affbox">W. H. Wilson Tang</a>,<sup>‡</sup> and  <a href="/pubmed/?term=McIntyre%20TM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23508960" class="affpopup" co-rid="_co_idm139867447876400" co-class="co-affbox">Thomas M. McIntyre</a><sup>‡,</sup><sup>1</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139867486128048"><h3 class="no_margin">Gang Zhou</h3><p>From the <sup>‡</sup>Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio 44195 and </p><div>Find articles by <a href="/pubmed/?term=Zhou%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23508960">Gang Zhou</a></div></div><div id="_co_idm139867446764160"><h3 class="no_margin">Gopal K. Marathe</h3><p>From the <sup>‡</sup>Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio 44195 and </p><div>Find articles by <a href="/pubmed/?term=Marathe%20GK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23508960">Gopal K. Marathe</a></div></div><div id="_co_idm139867443868784"><h3 class="no_margin">Jaana Hartiala</h3><p>the <sup>§</sup>Department of Preventive Medicine and Institute for Genetic Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California 90089</p><div>Find articles by <a href="/pubmed/?term=Hartiala%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23508960">Jaana Hartiala</a></div></div><div id="_co_idm139867447905456"><h3 class="no_margin">Stanley L. Hazen</h3><p>From the <sup>‡</sup>Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio 44195 and </p><div>Find articles by <a href="/pubmed/?term=Hazen%20SL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23508960">Stanley L. Hazen</a></div></div><div id="_co_idm139867447903344"><h3 class="no_margin">Hooman Allayee</h3><p>the <sup>§</sup>Department of Preventive Medicine and Institute for Genetic Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California 90089</p><div>Find articles by <a href="/pubmed/?term=Allayee%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23508960">Hooman Allayee</a></div></div><div id="_co_idm139867446807328"><h3 class="no_margin">W. H. Wilson Tang</h3><p>From the <sup>‡</sup>Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio 44195 and </p><div>Find articles by <a href="/pubmed/?term=Tang%20WH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23508960">W. H. Wilson Tang</a></div></div><div id="_co_idm139867447876400"><h3 class="no_margin">Thomas M. McIntyre</h3><p>From the <sup>‡</sup>Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio 44195 and </p><div>Find articles by <a href="/pubmed/?term=McIntyre%20TM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23508960">Thomas M. McIntyre</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm139867448119840_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139867448119840_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm139867448119840_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139867448119840_ai" style="display:none"><div class="fm-affl" id="aff1" lang="en">From the <sup>‡</sup>Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio 44195 and </div><div class="fm-affl" id="aff2" lang="en">the <sup>§</sup>Department of Preventive Medicine and Institute for Genetic Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California 90089</div><div id="cor1"><sup>1</sup> To whom correspondence should be addressed: Dept. of Cellular and Molecular Medicine, NE10, Lerner Research Inst., Cleveland Clinic Lerner College of Medicine, 9500 Euclid Ave., Cleveland, OH 44195.,  Tel.: 216-444-1048; Fax: 216-444-9404; E-mail: <a href="mailto:dev@null" data-email="gro.fcc@tytnicm" class="oemail">gro.fcc@tytnicm</a>.</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm139867448119840_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2012 Oct 12; Revised 2013 Mar 1</div></div><div class="permissions fm-panel half_rhythm hide" id="idm139867448119840_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> © 2013 by The American Society for Biochemistry and Molecular Biology, Inc.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC3636881/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="idm139867451761280" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139867451761280title">Abstract</h2><!--article-meta--><div><p id="__p5" class="p p-first-last">Aspirin is rapidly hydrolyzed within erythrocytes by a heterodimer of PAFAH1b2/PAFAH1b3 but also in plasma by an unidentified activity. Hydrolysis in both compartments was variable, with a 12-fold variation in plasma among 2226 Cleveland Clinic GeneBank patients. Platelet inhibition by aspirin was suppressed in plasma that rapidly hydrolyzed aspirin. Plasma aspirin hydrolysis was significantly higher in patients with coronary artery disease compared with control subjects (16.5 ± 4.4 <em>versus</em> 15.1 ± 3.7 nmol/ml/min; <em>p</em> = 3.4 × 10<sup>−8</sup>). A genome-wide association study of 2054 GeneBank subjects identified a single locus immediately adjacent to the <em>BCHE</em> (<span class="underline">b</span>utyryl<span class="underline">ch</span>olin<span class="underline">e</span>sterase) gene associated with plasma aspirin hydrolytic activity (lead SNP, rs6445035; <em>p</em> = 9.1 × 10<sup>−17</sup>). However, its penetrance was low, and plasma from an individual with an inactivating mutation in <em>BCHE</em> still effectively hydrolyzed aspirin. A second aspirin hydrolase was identified in plasma, the purification of which showed it to be homomeric PAFAH1b2. This is distinct from the erythrocyte PAFAH1b2/PAFAH1b3 heterodimer. Inhibitors showed that both butyrylcholinesterase (BChE) and PAFAH1b2 contribute to aspirin hydrolysis in plasma, with variation primarily reflecting non-genetic variation of BChE activity. Therefore, aspirin is hydrolyzed in plasma by two enzymes, BChE and a new extracellular form of platelet-activating factor acetylhydrolase, PAFAH1b2. Hydrolytic effectiveness varies widely primarily from non-genetic variation of BChE activity that affects aspirin bioavailability in blood and the ability of aspirin to inhibit platelet aggregation.</p></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Cyclooxygenase (COX) Pathway, Eicosanoid Regulation, Eicosanoid-specific Genes, Eicosanoid Biosynthesis, Platelets, Aspirin</span></div></div><div id="__sec1" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec1title">Introduction</h2><p id="__p6" class="p p-first">Aspirin (acetylsalicylic acid) use is estimated at 100 billion tablets annually (<a href="#B1" rid="B1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242661">1</a>) as an analgesic, to reduce mortality and re-infarction in individuals with unstable angina, and in secondary prevention in a range of cardiovascular diseases (<a href="#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242638">2</a>, <a href="#B3" rid="B3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242643">3</a>). The primary effect of aspirin is irreversible inhibition of cyclooxygenase (prostaglandin H synthase)-1 by acetylation of Ser-530 (<a href="#B4" rid="B4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242680">4</a>, <a href="#B5" rid="B5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242657">5</a>). The cyclooxygenase product prostaglandin H<sub>2</sub> is rapidly converted in platelets to unstable thromboxane A<sub>2</sub>, which aids in platelet responsiveness to ADP and collagen through the platelet thromboxane A<sub>2</sub> receptor (<a href="#B6" rid="B6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_343179470">6</a>).</p><p id="__p7">Aspirin inhibition of platelet thromboxane synthesis is irreversible (<a href="#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242641">2</a>, <a href="#B7" rid="B7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242630">7</a>, <a href="#B8" rid="B8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242686">8</a>), and although platelets cannot synthesize new cyclooxygenase-1, the half-life of circulating aspirin is just ∼20 min (<a href="#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242678">9</a>, <a href="#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242685">10</a>), so newly released platelets are not inhibited by the transient bolus of aspirin. Certain individuals or groups of individuals, <em>e.g.</em> diabetics or stroke survivors (<a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242679">11</a>–<a href="#B13" rid="B13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242650">13</a>), may not receive the full benefit of aspirin, although defining, measuring, and assessing such resistance to the therapeutic effects of aspirin are complex and incomplete (<a href="#B14" rid="B14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242684">14</a>–<a href="#B17" rid="B17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242658">17</a>). A single low dose of coated enteric aspirin fails to inhibit platelet function in half of those studied, reflecting varied bioavailability that is not genetically encoded (<a href="#B18" rid="B18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242668">18</a>).</p><p id="__p8">Aspirin is hydrolyzed in blood within erythrocytes (<a href="#B19" rid="B19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242682">19</a>) by a heterodimer of PAFAH1b2 and PAFHA1b3 (<a href="#B20" rid="B20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242646">20</a>) and also in plasma. The rate of aspirin hydrolysis by erythrocytes varies severalfold (<a href="#B20" rid="B20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242644">20</a>), with a larger variation in the rate of plasma hydrolysis (see below), so the relative contribution of the two compartments varies but is approximately similar. The identity of the enzyme in plasma that hydrolyzes aspirin remains unknown. Aspirin hydrolysis in plasma is not normally distributed (<a href="#B21" rid="B21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242637">21</a>) and is increased in patients with type 2 diabetes (<a href="#B22" rid="B22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242663">22</a>, <a href="#B23" rid="B23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242656">23</a>), atherosclerosis (<a href="#B24" rid="B24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242635">24</a>), and aspirin-sensitive asthma or cold urticaria (<a href="#B25" rid="B25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242649">25</a>) or after surgery (<a href="#B26" rid="B26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242674">26</a>).</p><p id="__p9">Aspirin hydrolysis is not an evolutionarily selected trait and so reflects the action of an existing esterase able to accept it as a substrate. Esterases able to accept aspirin as a substrate include butyrylcholinesterase (BChE<sup><a href="#FN2" rid="FN2" class=" fn">2</a></sup>; also known as pseudocholinesterase (<a href="#B21" rid="B21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242664">21</a>)) (<a href="#B27" rid="B27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242634">27</a>) and PON1 (<span class="underline">p</span>ara<span class="underline">o</span>xo<span class="underline">n</span>ase-<span class="underline">1</span>), which is additionally proposed to also hydrolyze aspirin nitrate, a novel anti-inflammatory agent (<a href="#B28" rid="B28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242648">28</a>). The actual contribution of these candidate enzymes to aspirin hydrolysis in plasma is undefined.</p><p id="__p10" class="p p-last">We identified enzymes in plasma that hydrolyze aspirin and found that BChE and a new extracellular form of PAFAH1b together account for aspirin hydrolysis in plasma. The rate of aspirin hydrolysis varied widely among donors, primarily from epigenetic BChE variation, and was sufficient to alter platelet sensitivity to aspirin inhibition.</p></div><div id="__sec2" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec2title">EXPERIMENTAL PROCEDURES</h2><div id="__sec3" class="sec sec-first-last"><div id="__sec4" class="sec sec-first-last"><div id="__sec5" class="sec sec-first"><p></p><h5 id="__sec5title" class="inline">Materials </h5><p id="__p11" class="p p-first-last">Aspirin, acetaminophen, Cibacron blue 3GA-agarose (type 3000-CL), potassium bromide, phenyl acetate, purified human plasma BChE, 5,5′-dithiobis(2-nitrobenzoic acid), and butyrylthiocholine iodide were from Sigma. Salicylic acid and HPLC-grade solvents (acetonitrile, formic acid, and water) were from Mallinckrodt Baker. ECL kits were from Amersham Biosciences. Polyclonal antibodies against BChE and PON1 were from Santa Cruz Biotechnology (Santa Cruz, CA), antibody against apoA-I was from R&amp;D Systems, antibody against PAFAH1b2 was from Sigma, and antibody against PAFAH1b3 was from Proteintech Group (Chicago, IL).</p></div><div id="__sec6" class="sec"><p></p><h5 id="__sec6title" class="inline">Aspirin Hydrolysis </h5><p id="__p12" class="p p-first-last">Salicylic acid from aspirin hydrolysis was isolated by reversed-phase HPLC and quantified by absorption with recovery corrected by an acetaminophen internal standard. Plasma (10 μl) was added to aspirin (4 m<span class="small-caps">m</span>) in 40 μl of PBS (37 °C, pH 7.2) for 2 h before stopping the reaction with 150 μl of acetonitrile containing 0.1% formic acid and 20 μg/ml acetaminophen, followed by centrifugation to remove precipitated proteins. The assay was linear over the plasma volumes used, and plasma aspirin hydrolysis was stable to freezing and storage at −80 °C for 24 months (<em>p</em> = 0.039). Aspirin and salicylic acid were separated by reversed-phase chromatography over Phenomenex ODS columns (150 × 2 mm, 5 μm) with 40:60 (v/v) acetonitrile/water (0.1% formic acid) at 0.4 ml/min and quantified at <em>A</em><sub>280</sub>. Data were analyzed by converting the area under the curve relative to salicylic acid standards minus non-enzymatic hydrolysis.</p></div><div id="__sec7" class="sec"><p></p><h5 id="__sec7title" class="inline">Plasma Aspirin Hydrolases </h5><p id="__p13" class="p p-first-last">Soluble material and lipoproteins were separated by gradient density centrifugation by adjusting the density of the plasma to 1.3 g/ml with potassium bromide and then layering over saline (9 ml onto 27 ml), followed by ultracentrifugation at 50,000 × <em>g</em> for 3 h. Recovered fractions were pooled and dialyzed against 20 m<span class="small-caps">m</span> Tris-Cl (pH 7.4) and then passed through conditioned Cibacron blue gel to remove albumin.</p></div><div id="__sec8" class="sec"><p></p><h5 id="__sec8title" class="inline">Expression and Purification of Recombinant PON1 </h5><p id="__p14" class="p p-first-last">His-tagged rabbit recombinant PON1 (clone G3C9; a gift of Dan S. Tawfik, Weizmann Institute of Science, Rehovot, Israel), highly similar to its human counterpart (<a href="#B29" rid="B29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242645">29</a>), was expressed in <em>Escherichia coli</em> (<a href="#B30" rid="B30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242652">30</a>). Lysate protein was precipitated by 55% (w/v) ammonium sulfate; recovered by centrifugation; dissolved in 50 m<span class="small-caps">m</span> Tris-Cl, 1 m<span class="small-caps">m</span> CaCl<sub>2</sub>, 0.1 m<span class="small-caps">m</span> dithiothreitol, 1 μ<span class="small-caps">m</span> pepstatin A, and 0.1% Tergitol (pH 8); and dialyzed overnight at 4 °C against this buffer and then against 50 m<span class="small-caps">m</span> Tris-Cl, 50 m<span class="small-caps">m</span> NaCl, 1 m<span class="small-caps">m</span> CaCl<sub>2</sub>, and 0.1% Tergitol (pH 8) for 4 h. The dialysate was passed over a nickel-nitrilotriacetic acid column, and bound protein was recovered with the first dialysis buffer and stored at 4 °C. Recombinant PON1 had a specific activity of (5.0 ± 0.1) × 10<sup>5</sup> units/mg of protein against phenyl acetate with protein determined with bicinchoninic acid.</p></div><div id="__sec9" class="sec"><p></p><h5 id="__sec9title" class="inline">Enzymatic Determinations </h5><p id="__p15" class="p p-first">BChE activity was measured by hydrolysis of 2 m<span class="small-caps">m</span> butyrylthiocholine iodide in phosphate buffer (pH 7.2) over 2 min at room temperature using 1 m<span class="small-caps">m</span> 5,5′-dithiobis(2-nitrobenzoic acid) (<a href="#B31" rid="B31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242662">31</a>) to detect thiocholine at <em>A</em><sub>412</sub> (13,260 <span class="small-caps">m</span><sup>−1</sup> cm<sup>−1</sup>). The arylesterase activity of PON1 was determined spectrophotometrically using phenyl acetate as the substrate (<a href="#B32" rid="B32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242654">32</a>). The assay contained 1 m<span class="small-caps">m</span> phenyl acetate, 20 m<span class="small-caps">m</span> Tris-Cl (pH 8.0), and 1 m<span class="small-caps">m</span> CaCl<sub>2</sub>. Blanks without enzyme were used to correct for spontaneous hydrolysis. Activity was calculated from a molar extinction coefficient at 270 nm (using differences in the absorbance of phenol <em>versus</em> phenyl acetate) of 1310 <span class="small-caps">m</span><sup>−1</sup> cm<sup>−1</sup>. One unit of arylesterase activity is defined as 1 μmol of phenyl acetate hydrolyzed per min.</p><p id="__p16" class="p p-last">Potential inhibition of BChE (0.6 μg) or platelet-activating factor acetylhydrolase (PAFAH; 0.5 μg) hydrolysis of 4 m<span class="small-caps">m</span> aspirin in plasma (10 μl) or by human serum albumin (50 mg) was assayed in a final volume of 50 μl of PBS for 2 h. Aggregation of washed human platelets (4 × 10<sup>8</sup>/ml) was initiated by stimulation with collagen (5 μg/ml) with stirring in a Chrono-log aggregometer. Platelets were incubated or not with the indicated amount of aspirin for 10 min prior to aggregometry.</p></div><div id="__sec10" class="sec"><p></p><h5 id="__sec10title" class="inline">Western Blotting </h5><p id="__p17" class="p p-first-last">ApoA-I, BChE, type I PAFAH (PAFAH1b2 and PAFAH1b3), and PON1 were visualized by immunoblotting after electrophoretic separation by SDS-PAGE. The resolved proteins were transferred to PVDF membranes (Millipore, Bedford, MA), probed with primary and secondary antibodies at the manufacturer's suggested dilution, and visualized using extended chemiluminescence reagent and x-ray film.</p></div><div id="__sec11" class="sec"><p></p><h5 id="__sec11title" class="inline">Human Samples </h5><p id="__p18" class="p p-first-last">The Cleveland Clinic GeneBank study is a single site sample repository generated from consecutive patients undergoing elective diagnostic coronary angiography or elective cardiac computed tomographic angiography with extensive clinical and laboratory characterization and longitudinal observation. Subject recruitment occurred between 2001 and 2006. Ethnicity was self-reported, and information regarding demographics, medical history, and medication use was obtained in patient interviews and confirmed by chart reviews. All clinical outcome data were verified by source documentation. Coronary artery disease (CAD) was defined as adjudicated diagnoses of stable or unstable angina, myocardial infarction (adjudicated definition based on defined electrocardiographic changes or elevated cardiac enzymes), angiographic evidence of ≥50% stenosis of one or more major epicardial vessels, and/or a history of known CAD (documented myocardial infarction, CAD, or history of revascularization). Control subjects were classified as having &lt;30% stenosis in any vessel and no history of known CAD. The GeneBank cohort has been used previously for discovery and replication of novel genes and risk factors for atherosclerotic disease (<a href="#B33" rid="B33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242671">33</a>–<a href="#B36" rid="B36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242653">36</a>). For this study, aspirin hydrolase activity was determined in plasma from 2226 subjects. Activity was obtained from a single measurement, which was validated by reanalysis of 285 randomly selected samples. All patients provided written informed consent prior to being enrolled in GeneBank, and the study was approved by the Institutional Review Board of the Cleveland Clinic. BChE null plasma was a gift from Dr. Oksana Lockridge (Nebraska Medical Center).</p></div><div id="__sec12" class="sec"><p></p><h5 id="__sec12title" class="inline">Genome-wide Association Study (GWAS) </h5><p id="__p19" class="p p-first-last">Genome-wide genotyping of SNPs was performed on the Affymetrix genome-wide human array 6.0 chip. Using these data and those from 120 phased chromosomes from the HapMap CEU samples (HapMap r22 release, NCBI build 36), genotypes were imputed for untyped autosomal SNPs across the genome using MACH 1.0 software. All imputations were done on the forward (+)-strand using 562,554 genotyped SNPS that had passed quality control filters. Quality control filters for the imputed data set excluded SNPs with Hardy-Weinberg equilibrium <em>p</em> values &lt;0.0001, call rates &lt;97%, or minor allele frequencies &lt;1% and individuals with &lt;90% call rates. This resulted in 2,421,770 autosomal SNPs in 2054 subjects in whom plasma aspirin hydrolytic activity was available for analysis.</p></div><div id="__sec13" class="sec sec-last"><p></p><h5 id="__sec13title" class="inline">Statistics </h5><p id="__p20" class="p p-first-last">Each experiment was repeated at least three times, and each assay was performed in triplicate. Genome-wide linear regression analyses were used to identify loci associated with plasma aspirin hydrolase activity after adjustment for age and gender under an additive model. Genetic analyses were carried out with PLINK v1.07, and a genome-wide <em>p</em> value of &lt;5 × 10<sup>−8</sup> was considered significant evidence for association.</p></div></div></div></div><div id="__sec14" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec14title">RESULTS</h2><div id="__sec15" class="sec sec-first-last"><div id="__sec16" class="sec sec-first-last"><div id="__sec17" class="sec sec-first"><p></p><h5 id="__sec17title" class="inline">Aspirin Is Hydrolyzed in Plasma, Hydrolysis Is Highly Variable, and Extracellular Hydrolysis Affects Platelet Inhibition </h5><p id="__p21" class="p p-first">Aspirin was hydrolyzed in cell-free plasma but with considerable variation. The rate of hydrolysis ranged by 7-fold from 3.67 to 24.70 nmol/ml/min among 11 healthy donors (<a href="/pmc/articles/PMC3636881/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1</span></a><em>A</em>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC3636881/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139867435985952" class="figure"><a href="/pmc/articles/PMC3636881/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3636881_zbc0221347740001.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is zbc0221347740001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3636881/bin/zbc0221347740001.jpg"></a></div><div id="largeobj_idm139867435985952" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3636881/figure/F1/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC3636881/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">FIGURE 1.</a></div><!--caption a7--><div class="caption"><p id="__p22"><strong>Aspirin hydrolytic activity varies among plasma donors and alters the effectiveness of platelet inhibition by aspirin.</strong>
<em>A</em>, box and whisker plot of plasma aspirin hydrolytic activity. Aspirin hydrolysis in plasma from 11 normal donors is depicted with the maximum (24.72 nmol/ml/min), minimum (3.66 nmol/ml/min), lowest and highest quartile (5.67 and 10.54 nmol/ml/min), and median (7.66 nmol/ml/min). Data are presented as the mean ± S.D. (<em>n</em> = 3). <em>B</em>, aspirin inhibits platelet aggregation in a concentration-dependent manner. Washed human platelets (4 × 10<sup>8</sup>/ml) were incubated with the indicated amount of aspirin (<em>ASA</em>) for 10 min prior to stimulation by collagen (5 μg/ml). <em>C</em>, inhibition of aggregation differs after incubation with aspirin in plasma with high and low aspirin hydrolytic activities. Aspirin (33 μ<span class="small-caps">m</span>) was preincubated in platelet-poor plasma from a donor with faster (8.75 nmol/ml/min) or slower (3.75 nmol/ml/min) aspirin hydrolytic activity for 30 min before mixing with washed platelets for another 10 min prior to stimulation with 5 μg/ml collagen (<em>n</em> = 3). <em>D</em>, high-throughput HPLC analysis of aspirin hydrolysis in 2226 plasma samples from the GeneBank cohort. Activity was obtained from a single measurement, which was validated by reanalysis of 285 randomly selected samples. <em>E</em>, plasma aspirin hydrolytic activity is significantly higher in patients with CAD compared with control subjects (16.5 ± 4.4 <em>versus</em> 15.1 ± 3.7 nmol/ml/min, respectively; *, <em>p</em> = 3.4 × 10<sup>−8</sup>) in the GeneBank cohort.</p></div></div></div><p id="__p23">Aspirin irreversibly inactivates platelet cyclooxygenase and thromboxane A<sub>2</sub> production, thereby inhibiting aggregation induced by weak agonists. Aspirin inhibited platelet aggregation induced by collagen in a concentration-dependent fashion (<a href="/pmc/articles/PMC3636881/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1</span></a><em>B</em>). Platelet-poor plasma reduced the effectiveness of aspirin in suppressing this aggregation, but again, the effectiveness of plasma in blocking aspirin inhibition varied among donors. Plasma from donor 6, able to hydrolyze aspirin only at 3.75 nmol/ml/min, was less effective in suppressing platelet aggregation by 33 μ<span class="small-caps">m</span> aspirin compared with plasma from donor 3, which hydrolyzed aspirin at a rate of 8.75 nmol/ml/min (<a href="/pmc/articles/PMC3636881/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1</span></a><em>C</em>).</p><p id="__p24" class="p p-last">We established a high-throughput assay to examine population variation in plasma aspirin hydrolytic activity. These assays were carried out in plasma from 2226 individuals enrolled in the GeneBank study, with 1928 individuals having CAD and 298 subjects being defined as controls. Among these subjects, the minimum and maximum of aspirin hydrolytic activity were 3.06 and 37.38 nmol/ml/min, respectively, with a mean of 16.33 nmol/ml/min and a standard deviation of 4.36 nmol/ml/min (<a href="/pmc/articles/PMC3636881/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1</span></a><em>D</em>). Values from duplicate measurements in 285 randomly selected samples yielded high correlations (data not shown). Thus, variation in aspirin hydrolytic activity among the 2226 GeneBank subjects was ∼12-fold and similar to the range observed in healthy donors. Furthermore, aspirin hydrolytic activity was significantly higher (<em>p</em> = 3.4 × 10<sup>−8</sup>) in CAD cases compared with control subjects (<a href="/pmc/articles/PMC3636881/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1</span></a><em>E</em>).</p></div><div id="__sec18" class="sec"><p></p><h5 id="__sec18title" class="inline">GWAS for Plasma Aspirin Hydrolase Activity </h5><p id="__p25" class="p p-first">We sought to identify the genetic determinants of variation in plasma aspirin hydrolytic activity using an unbiased approach. We performed a GWAS analysis for aspirin hydrolytic activity using ∼2.4 million genotyped and imputed SNPs in 2054 GeneBank subjects (all of Caucasian ancestry) for whom both genotype and phenotype data were available. The Q-Q plot from these analyses is shown in <a href="/pmc/articles/PMC3636881/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2</span></a><em>A</em>, and the observed genomic control factor was 1.0, suggesting that the GWAS results were not confounded by underlying population stratification.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC3636881/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139867444603936" class="figure"><a href="/pmc/articles/PMC3636881/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3636881_zbc0221347740002.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is zbc0221347740002.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3636881/bin/zbc0221347740002.jpg"></a></div><div id="largeobj_idm139867444603936" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3636881/figure/F2/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC3636881/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">FIGURE 2.</a></div><!--caption a7--><div class="caption"><p id="__p26"><strong>The <em>BCHE</em> locus is a major (but not the sole) determinant of plasma aspirin hydrolase activity.</strong>
<em>A</em>, as shown by the Q-Q plot from the GWAS analyses, the obtained <em>p</em> values deviate from those expected by chance, suggesting that a subset of these signals reflect true associations. <em>B</em>, Manhattan plot showing that plasma aspirin hydrolase activity is controlled predominantly by a single locus on chromosome 3q26.1 containing <em>BCHE</em>, with the lead SNP (rs6445035) yielding a highly significant <em>p</em> value of 9.1 × 10<sup>−17</sup>. <em>C</em>, regional plot for the 1-megabase region centered around <em>BCHE</em> demonstrates that other SNPs yielding significant <em>p</em> values are in moderate-to-high linkage disequilibrium with rs6445035. <em>cM/Mb</em>, centimorgans/megabase. <em>D</em>, aspirin hydrolysis as a function of genotype for rs6445035 demonstrates that each copy of the minor A allele lowers activity by ∼1.2 nmol/ml/min. The mean ± S.D. is indicated above each genotype group, and the number of subjects is shown in <em>parentheses. E</em>, BChE is not the only contributor to plasma aspirin hydrolysis. Plasma was separated by density gradient centrifugation, and fraction 1 containing aspirin hydrolytic activity was partially purified by Cibacron blue chromatography. BChE protein in this fraction was assessed by aspirin hydrolytic activity quantified as described under “Experimental Procedures” (<em>upper panel</em>) or by Western blotting (<em>lower panel</em>) in comparison with known quantities of BChE purified from human plasma. <em>F</em>, BChE thioesterase and aspirin hydrolytic activities were determined in normal human plasma and plasma from an individual with an inactivating null mutation in <em>BCHE</em>. Data are presented as the mean ± S.D. (<em>n</em> = 3).</p></div></div></div><p id="__p27">As shown by the Manhattan plot in <a href="/pmc/articles/PMC3636881/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2</span></a><em>B</em>, plasma aspirin hydrolytic activity was controlled primarily by a single locus on chromosome 3q26.1 containing <em>BCHE</em>, where the lead SNP, rs6445035 (G → A), yielded a highly significant <em>p</em> value of 9.1 × 10<sup>−17</sup>. <em>BCHE</em> encodes the enzyme BChE, homozygous mutations of which confer susceptibility to prolonged apnea after administration of the muscle relaxant suxamethonium (succinylcholine) (<a href="#B37" rid="B37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242651">37</a>). A regional plot of 1 megabase centered around <em>BCHE</em> also revealed that other SNPs yielding significant <em>p</em> values in this region are in moderate-to-high linkage disequilibrium with rs6445035 (<a href="/pmc/articles/PMC3636881/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2</span></a><em>C</em>).</p><p id="__p28">As shown in <a href="/pmc/articles/PMC3636881/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2</span></a><em>D</em>, each copy of the A allele lowered aspirin hydrolytic activity by ∼1.2 nmol/ml/min. The minor allele (A) of rs6445035 had a frequency of 0.19, explained 3.3% of the variation in aspirin hydrolytic activity, and was located 10.6 kb centromeric to the 3′ terminus of <em>BCHE</em> (<a href="/pmc/articles/PMC3636881/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2</span></a><em>C</em>).</p><p id="__p29" class="p p-last">To determine whether the other SNPs in this region represent independent association signals, we also ran analyses taking into account the effect of the lead SNP (rs6445035). However, these conditional analyses did not reveal other SNPs associated with aspirin hydrolase activity at the genome-wide threshold for significance (data not shown).</p></div><div id="__sec19" class="sec"><p></p><h5 id="__sec19title" class="inline">Aspirin Hydrolytic Activity, in Addition to BChE, Is Present in Plasma </h5><p id="__p30" class="p p-first">Our genetic studies implicated BChE as a plasma aspirin esterase, which is supported by aspirin hydrolysis by purified BChE (<a href="#B27" rid="B27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242640">27</a>). However, Western blotting showed that partially purified material from the soluble faction of plasma contained little of the enzyme, but at least 200 ng of purified BChE was required to achieve aspirin hydrolysis equivalent to that in the purified fraction (<a href="/pmc/articles/PMC3636881/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2</span></a><em>E</em>).</p><p id="__p31" class="p p-last">These results suggest that human plasma may contain additional aspirin hydrolytic activity. To investigate this, we obtained plasma from an individual homozygous for a frameshift mutation in <em>BCHE</em>, which leads to a premature stop codon (<a href="#B38" rid="B38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242676">38</a>). Although plasma from this individual was unable to hydrolyze the BChE substrate butyrylthiocholine (<a href="/pmc/articles/PMC3636881/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2</span></a><em>F</em>), this complete loss of BChE activity did not result in a corresponding loss of aspirin hydrolysis.</p></div><div id="__sec20" class="sec"><p></p><h5 id="__sec20title" class="inline">Type I PAFAH Is a Candidate Plasma Aspirin Esterase </h5><p id="__p32" class="p p-first">Aspirin hydrolytic activity is reported (<a href="#B28" rid="B28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242659">28</a>) to physically associate with HDL, potentially reflecting PON1 that additionally hydrolyzes clopidogrel (<a href="#B39" rid="B39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242667">39</a>). In contrast, density gradient separation of plasma showed that aspirin esterase activity was a soluble activity and that apoA-I-containing lipoprotein particles were essentially devoid of activity (<a href="/pmc/articles/PMC3636881/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3</span></a><em>A</em>). This conclusion was supported by the inability of functional recombinant PON1 to hydrolyze aspirin (<a href="/pmc/articles/PMC3636881/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3</span></a><em>B</em>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC3636881/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139867448111856" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.
Object name is zbc0221347740003.jpg" title="An external file that holds a picture, illustration, etc.
Object name is zbc0221347740003.jpg" src="/pmc/articles/PMC3636881/bin/zbc0221347740003.jpg"></div></a><div id="largeobj_idm139867448111856" class="largeobj-link align_right" style=""><a href="/pmc/articles/PMC3636881/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"></a><a target="object" href="/pmc/articles/PMC3636881/figure/F3/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC3636881/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">FIGURE 3.</a></div><!--caption a7--><div class="caption"><p id="__p33"><strong>Type I PAFAH is a plasma aspirin hydrolase.</strong>
<em>A</em>, PON1 fails to localize with plasma aspirin hydrolytic activity. Plasma that had been anticoagulated with heparin to avoid PON1 inhibition by EDTA and lipoproteins were separated by density gradient centrifugation before aspirin hydrolytic activity, arylesterase activity, PON1 protein, and HDL-associated apoA-I were detected by Western blotting. <em>B</em>, recombinant PON1 does not hydrolyze aspirin. Arylesterase activity and aspirin hydrolysis by plasma and recombinant PON1 (<em>rPON1</em>; 2.5 μg) were determined as described under “Experimental Procedures.” Data are presented as the mean ± S.D. (<em>n</em> = 3). <em>C</em>, PAFAH1b2 is present in BChE null plasma and plasma from healthy individuals. Western blotting for PAFAH1b2 or PAFAH1b3 was performed with 5 μl of each fraction from a gradient centrifugation (<em>upper panel</em>) or from seven different normal donors' plasma and BChE null plasma (<em>lower panel</em>). RBC lysates were the positive control (<em>n</em> = 3).</p></div></div></div><p id="__p34" class="p p-last">Purification of soluble fraction 1 and mass spectrometry of candidate proteins as described (<a href="#B20" rid="B20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242633">20</a>) revealed the presence of PAFAH1b2 in plasma (data not shown.) Type I PAFAH hydrolyzes acetylated phospholipids but additionally accepts aspirin as a substrate (<a href="#B20" rid="B20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242665">20</a>). This intracellular enzyme is a trimer containing a common LIS1 non-catalytic subunit and either or both PAFAH1b2 and PAFAH1b3 catalytically active esterases (<a href="#B40" rid="B40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242639">40</a>). This is an intracellular enzyme of brain and erythrocytes, but Western blotting showed that PAFAH1b2 was uniformly present in normal plasma (<a href="/pmc/articles/PMC3636881/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3</span></a><em>C</em>). PAFAH1b2 was also present in plasma from the patient with the frameshift mutation in <em>BCHE</em>. Notably, the plasma enzyme was homodimeric PAFAH1b2, whereas the erythrocyte enzyme was the PAFAH1b2/PAFAH1b3 heterodimer. These are therefore distinct enzymes, and the plasma enzyme does not arise from erythrocyte lysis. We examined the genomic regions containing the genes encoding PAFAH1b2 and PAFAH1b3, but SNPs at these loci were not associated with plasma aspirin hydrolytic activity after correcting for multiple testing (data not shown).</p></div><div id="__sec21" class="sec sec-last"><p></p><h5 id="__sec21title" class="inline">Both BChE and Type I PAFAH Contribute to Plasma Aspirin Hydrolysis </h5><p id="__p35" class="p p-first">Recombinant PAFAH1b2 hydrolyzed aspirin, and the irreversible P<sub>2</sub>X<sub>7</sub> inhibitor oxidized ATP (oATP) inhibited this activity (<a href="/pmc/articles/PMC3636881/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4</span></a><em>A</em>). Purified BChE was largely unaffected by oATP, but BChE hydrolysis of aspirin was abolished by the inhibitor procainamide. Conversely, PAFAH was only modestly affected by procainamide. We found that oATP fully abolished aspirin hydrolysis in plasma from the BChE null donor, implicating PAFAH1b2 as the non-BChE aspirin hydrolytic activity.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F4" co-legend-rid="lgnd_F4"><a href="/pmc/articles/PMC3636881/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139867447162144" class="figure"><a href="/pmc/articles/PMC3636881/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3636881_zbc0221347740004.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is zbc0221347740004.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3636881/bin/zbc0221347740004.jpg"></a></div><div id="largeobj_idm139867447162144" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3636881/figure/F4/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_F4"><div><a class="figpopup" href="/pmc/articles/PMC3636881/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4">FIGURE 4.</a></div><!--caption a7--><div class="caption"><p id="__p36"><strong>BChE and type I PAFAH contribute to plasma aspirin hydrolysis.</strong>
<em>A</em>, residual aspirin hydrolytic activity in BChE null plasma behaves as type I PAFAH. The effects of oATP or procainamide on aspirin hydrolysis were examined with recombinant PAFAH1b2 (<em>rPAFAH1b2</em>), purified BChE, or BChE null plasma. <em>B</em>, BChE and type I PAFAH act in normal plasma to consume aspirin. Aspirin hydrolysis in plasma from seven normal donors in the presence of procainamide or oATP was quantified as described for <em>A</em>. Data are presented as the mean ± S.D. (<em>n</em> = 3). <em>C</em>, plasma alters the aspirin hydrolytic concentration-response relationship of BChE. Shown is the aspirin hydrolytic activity in a total volume of 50 μl containing purified BChE (4 μg; <em>middle panel</em>), recombinant PAFAH1b2 (0.8 μg; <em>right panel</em>), the indicated aspirin concentrations, and plasma (10 μl) from a donor with high (<em>plasma1</em>) or low (<em>plasma2</em>) endogenous aspirin hydrolytic activity (<em>left panel</em>).</p></div></div></div><p id="__p37">We compared the effectiveness of these two inhibitors in plasma from seven normal donors and observed that both inhibitors suppressed aspirin hydrolysis (<a href="/pmc/articles/PMC3636881/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4</span></a><em>B</em>). The procainamide-resistant activity (PAFAH1b2) was relatively uniform among donors, whereas the oATP-resistant activity (BChE) varied among donors in concert with total activity.</p><p id="__p38" class="p p-last">We determined whether aspirin hydrolysis of recombinant PAFAH1b2 or BChE was differentially affected in plasma from a donor with higher aspirin hydrolytic activity compared with plasma from a donor with slower hydrolysis of aspirin (<a href="/pmc/articles/PMC3636881/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4</span></a><em>C</em>). We found that BChE readily responded to plasma, so its velocity was greater in plasma with higher endogenous activity compared with hydrolysis in plasma with slower endogenous activity. In contrast, aspirin hydrolysis by PAFAH1b2 was equivalent in the two plasmas.</p></div></div></div></div><div id="__sec22" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec22title">DISCUSSION</h2><p id="__p39" class="p p-first">Aspirin has been in extensive use for well over 100 years, and its unique properties ensure its continued use (<a href="#B41" rid="B41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242681">41</a>). Not all individuals or members of groups appear to receive the benefits of aspirin administration (<a href="#B14" rid="B14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242683">14</a>–<a href="#B17" rid="B17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242677">17</a>), but whether this phenomenon of “aspirin resistance” is a valid description or even identifiable given difficulties in clinical measurement of platelet function (<a href="#B17" rid="B17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242660">17</a>) is debated (<a href="#B14" rid="B14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242632">14</a>, <a href="#B15" rid="B15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242670">15</a>). Platelet resistance to aspirin inhibition is, however, present in <em>ex vivo</em> assays (<a href="#B42" rid="B42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242672">42</a>) in certain <em>in vivo</em> studies (<a href="#B15" rid="B15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242675">15</a>) and correlates with measures of type 2 diabetes (<a href="#B22" rid="B22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242655">22</a>, <a href="#B23" rid="B23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242647">23</a>).</p><p id="__p40">Aspirin was hydrolyzed in cell-free plasma, and this activity varied widely among normal donors. This is relevant because the effectiveness of aspirin at a dose approximating the maximal plasma concentration after ingestion of a standard 325-mg dose (<a href="#B43" rid="B43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242636">43</a>) was affected with this intrinsic plasma hydrolytic activity. We found a slight but significant higher plasma aspirin hydrolytic activity in patients with CAD compared with control patients.</p><p id="__p41">We used GWAS to determine whether variation in aspirin consumption included a genetic component and to elucidate candidate loci affecting the undefined hydrolytic activity. The rate of aspirin hydrolysis in plasma of 2226 GeneBank patients varied by 12-fold and was associated strongly with a single SNP on chromosome 3q26.1. rs6445035 is immediately 3′ of <em>BCHE</em>, so this region either may contain enhancer elements that control expression of <em>BCHE</em> or is in linkage disequilibrium with a coding variant(s) that affects enzymatic activity. However, the genetic effects of rs6445035 were relatively weak and explained only 3.3% of the variation in plasma aspirin hydrolytic activity. BChE circulates as a tetramer with complex kinetics (<a href="#B44" rid="B44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_343179469">44</a>) subject to environmental effects (<a href="#B45" rid="B45" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242666">45</a>), and this epigenetic variation is the primary modifier of plasma BChE activity.</p><p id="__p42">Plasma contained a second aspirin hydrolytic activity, which was not HDL-associated or PON1 (<a href="#B28" rid="B28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242642">28</a>). Instead, PAFAH1b2, the α2 subunit of PAFAH I, was present as an extracellular enzyme. Type I PAFAH is an α1/α2 heterodimer composed of independent genes (<em>PAFAH1b2</em> and <em>PAFAH1b3</em>) that are independently regulated and have independent roles (<a href="#B46" rid="B46" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242631">46</a>–<a href="#B48" rid="B48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242669">48</a>). We previously identified the α1/α2 heterodimer as the aspirin hydrolytic enzyme of erythrocytes (<a href="#B20" rid="B20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_309242673">20</a>), so the novel plasma α2 enzyme shows that this extracellular enzyme is not derived from lysed erythrocytes.</p><p id="__p43">Procainamide inhibition of BChE and oATP inhibition of type I PAFAH showed that both enzymes contribute to plasma aspirin esterase activity. The total amount of the aspirin hydrolytic activity in plasma and its composition are highly variable, with the majority of the variation associated with non-genetic modulation of BChE activity.</p><p id="__p44" class="p p-last">Aspirin inactivation in the vascular compartment modifies the effectiveness of aspirin in inhibiting platelet aggregation, which reflects the contributions of plasma PAFAH1b2, plasma BChE, and erythrocyte PAFAH1b2/PAFAH1b3 heterodimers. All of these enzymes vary among individuals, yielding a complex pattern of aspirin consumption that affects the effectiveness of physiologically relevant doses of aspirin in inhibiting platelet function.</p></div><div id="idm139867444832688" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139867444832688title">Acknowledgments</h2><div class="sec"><p id="__p52">We appreciate the significant help of Barbara Sullivan, Sarah Neale, and Shirley Mann in accessing and providing GeneBank samples. We thank Dr. Belinda Willard and the Proteomic Mass Spectrometry Core Facility. We are indebted to Dr. Oksana Lockridge for the gift of BChE null plasma, and we appreciate the gift of the PON1 construct from Dan S. Tawfik.</p></div></div><div id="idm139867446152176" class="tsec sec headless whole_rhythm"><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN1"><sup>*</sup>This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL087018, AA017748, and P50 HL081011. The Cleveland Clinic GeneBank study was supported by NHLBI Grants P01 HL098055, P01 HL076491, R01 HL103866, P20 HL113452, and R01 HL103931 and by the Cleveland Clinic Clinical Research Unit of the Case Western Reserve University through National Institutes of Health Clinical and Translational Science Award Grant 1UL1RR024989.</p></div></div><div id="idm139867444780608" class="tsec sec headless whole_rhythm"><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN2"><sup>2</sup>The abbreviations used are:
</p><div class="def-list"><dl class="labeled-list"><dt id="G1">BChE</dt><dd>butyrylcholinesterase</dd><dt id="G2">PAFAH</dt><dd>platelet-activating factor acetylhydrolase</dd><dt id="G3">CAD</dt><dd>coronary artery disease</dd><dt id="G4">GWAS</dt><dd>genome-wide association study</dd><dt id="G5">oATP</dt><dd>oxidized ATP.</dd></dl></div><p></p></div></div><div id="idm139867442044368" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139867442044368title">REFERENCES</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="B1">1. <span class="mixed-citation">
Warner T. D., Mitchell J. A. (2002) <span class="ref-title">Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?</span>
<span class="ref-journal">Proc. Natl. Acad. Sci. U.S.A</span>. <span class="ref-vol">99</span>, 13371–13373 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC129677/">PMC free article</a>]</span> [<a href="/pubmed/12374850" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+U.S.A&amp;title=Cyclooxygenase-3+(COX-3):+filling+in+the+gaps+toward+a+COX+continuum?&amp;author=T.+D.+Warner&amp;author=J.+A.+Mitchell&amp;volume=99&amp;publication_year=2002&amp;pages=13371-13373&amp;pmid=12374850&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B2">2. <span class="mixed-citation">
Awtry E. H., Loscalzo J. (2000) <span class="ref-title">Aspirin</span>. <span class="ref-journal">Circulation</span>
<span class="ref-vol">101</span>, 1206–1218 [<a href="/pubmed/10715270" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Aspirin&amp;author=E.+H.+Awtry&amp;author=J.+Loscalzo&amp;volume=101&amp;publication_year=2000&amp;pages=1206-1218&amp;pmid=10715270&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B3">3. <span class="mixed-citation">
Antithrombotic Trialists' (ATT) Collaboration, Baigent C., Blackwell L., Collins R., Emberson J., Godwin J., Peto R., Buring J., Hennekens C., Kearney P., Meade T., Patrono C., Roncaglioni M. C., Zanchetti A. (2009) <span class="ref-title">Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials</span>. <span class="ref-journal">Lancet</span>
<span class="ref-vol">373</span>, 1849–1860 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2715005/">PMC free article</a>]</span> [<a href="/pubmed/19482214" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Aspirin+in+the+primary+and+secondary+prevention+of+vascular+disease:+collaborative+meta-analysis+of+individual+participant+data+from+randomised+trials&amp;author=C.+Baigent&amp;author=L.+Blackwell&amp;author=R.+Collins&amp;author=J.+Emberson&amp;author=J.+Godwin&amp;volume=373&amp;publication_year=2009&amp;pages=1849-1860&amp;pmid=19482214&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B4">4. <span class="mixed-citation">
Smith W. L., DeWitt D. L., Kraemer S. A., Andrews M. J., Hla T., Maciag T., Shimokawa T. (1990) <span class="ref-title">Structure-function relationships in sheep, mouse, and human prostaglandin endoperoxide G/H synthases</span>. <span class="ref-journal">Adv. Prostaglandin Thromboxane Leukot. Res</span>. <span class="ref-vol">20</span>, 14–21 [<a href="/pubmed/2144687" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Adv.+Prostaglandin+Thromboxane+Leukot.+Res&amp;title=Structure-function+relationships+in+sheep,+mouse,+and+human+prostaglandin+endoperoxide+G/H+synthases&amp;author=W.+L.+Smith&amp;author=D.+L.+DeWitt&amp;author=S.+A.+Kraemer&amp;author=M.+J.+Andrews&amp;author=T.+Hla&amp;volume=20&amp;publication_year=1990&amp;pages=14-21&amp;pmid=2144687&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B5">5. <span class="mixed-citation">
Roth G. J., Stanford N., Majerus P. W. (1975) <span class="ref-title">Acetylation of prostaglandin synthase by aspirin</span>. <span class="ref-journal">Proc. Natl. Acad. Sci. U.S.A</span>. <span class="ref-vol">72</span>, 3073–3076 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC432922/">PMC free article</a>]</span> [<a href="/pubmed/810797" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+U.S.A&amp;title=Acetylation+of+prostaglandin+synthase+by+aspirin&amp;author=G.+J.+Roth&amp;author=N.+Stanford&amp;author=P.+W.+Majerus&amp;volume=72&amp;publication_year=1975&amp;pages=3073-3076&amp;pmid=810797&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B6">6. <span class="mixed-citation">
FitzGerald G. A. (1991) <span class="ref-title">Mechanisms of platelet activation: thromboxane A<sub>2</sub> as an amplifying signal for other agonists</span>. <span class="ref-journal">Am. J. Cardiol</span>. <span class="ref-vol">68</span>, 11B–15B [<a href="/pubmed/1892057" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am.+J.+Cardiol&amp;title=Mechanisms+of+platelet+activation:+thromboxane+A2+as+an+amplifying+signal+for+other+agonists&amp;author=G.+A.+FitzGerald&amp;volume=68&amp;publication_year=1991&amp;pages=11B-15B&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B7">7. <span class="mixed-citation">
Higgs G. A., Salmon J. A., Henderson B., Vane J. R. (1987) <span class="ref-title">Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and anti-inflammatory activity</span>. <span class="ref-journal">Proc. Natl. Acad. Sci. U.S.A</span>. <span class="ref-vol">84</span>, 1417–1420 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC304441/">PMC free article</a>]</span> [<a href="/pubmed/3103135" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+U.S.A&amp;title=Pharmacokinetics+of+aspirin+and+salicylate+in+relation+to+inhibition+of+arachidonate+cyclooxygenase+and+anti-inflammatory+activity&amp;author=G.+A.+Higgs&amp;author=J.+A.+Salmon&amp;author=B.+Henderson&amp;author=J.+R.+Vane&amp;volume=84&amp;publication_year=1987&amp;pages=1417-1420&amp;pmid=3103135&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B8">8. <span class="mixed-citation">
Needs C. J., Brooks P. M. (1985) <span class="ref-title">Clinical pharmacokinetics of the salicylates</span>. <span class="ref-journal">Clin. Pharmacokinet</span>. <span class="ref-vol">10</span>, 164–177 [<a href="/pubmed/3888490" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin.+Pharmacokinet&amp;title=Clinical+pharmacokinetics+of+the+salicylates&amp;author=C.+J.+Needs&amp;author=P.+M.+Brooks&amp;volume=10&amp;publication_year=1985&amp;pages=164-177&amp;pmid=3888490&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B9">9. <span class="mixed-citation">
Levy G. (1965) <span class="ref-title">Aspirin, absorption rate and analgesic effect</span>. <span class="ref-journal">Anesth. Analg</span>. <span class="ref-vol">44</span>, 837–841 [<a href="/pubmed/5891911" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Anesth.+Analg&amp;title=Aspirin,+absorption+rate+and+analgesic+effect&amp;author=G.+Levy&amp;volume=44&amp;publication_year=1965&amp;pages=837-841&amp;pmid=5891911&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B10">10. <span class="mixed-citation">
Rowland M., Riegelman S., Harris P. A., Sholkoff S. D. (1972) <span class="ref-title">Absorption kinetics of aspirin in man following oral administration of an aqueous solution</span>. <span class="ref-journal">J. Pharm. Sci</span>. <span class="ref-vol">61</span>, 379–385 [<a href="/pubmed/5013373" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Pharm.+Sci&amp;title=Absorption+kinetics+of+aspirin+in+man+following+oral+administration+of+an+aqueous+solution&amp;author=M.+Rowland&amp;author=S.+Riegelman&amp;author=P.+A.+Harris&amp;author=S.+D.+Sholkoff&amp;volume=61&amp;publication_year=1972&amp;pages=379-385&amp;pmid=5013373&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B11">11. <span class="mixed-citation">
Helgason C. M., Bolin K. M., Hoff J. A., Winkler S. R., Mangat A., Tortorice K. L., Brace L. D. (1994) <span class="ref-title">Development of aspirin resistance in persons with previous ischemic stroke</span>. <span class="ref-journal">Stroke</span>
<span class="ref-vol">25</span>, 2331–2336 [<a href="/pubmed/7974569" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Stroke&amp;title=Development+of+aspirin+resistance+in+persons+with+previous+ischemic+stroke&amp;author=C.+M.+Helgason&amp;author=K.+M.+Bolin&amp;author=J.+A.+Hoff&amp;author=S.+R.+Winkler&amp;author=A.+Mangat&amp;volume=25&amp;publication_year=1994&amp;pages=2331-2336&amp;pmid=7974569&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B12">12. <span class="mixed-citation">
Alberts M. J., Bergman D. L., Molner E., Jovanovic B. D., Ushiwata I., Teruya J. (2004) <span class="ref-title">Antiplatelet effect of aspirin in patients with cerebrovascular disease</span>. <span class="ref-journal">Stroke</span>
<span class="ref-vol">35</span>, 175–178 [<a href="/pubmed/14671242" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Stroke&amp;title=Antiplatelet+effect+of+aspirin+in+patients+with+cerebrovascular+disease&amp;author=M.+J.+Alberts&amp;author=D.+L.+Bergman&amp;author=E.+Molner&amp;author=B.+D.+Jovanovic&amp;author=I.+Ushiwata&amp;volume=35&amp;publication_year=2004&amp;pages=175-178&amp;pmid=14671242&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B13">13. <span class="mixed-citation">
Helgason C. M., Tortorice K. L., Winkler S. R., Penney D. W., Schuler J. J., McClelland T. J., Brace L. D. (1993) <span class="ref-title">Aspirin response and failure in cerebral infarction</span>. <span class="ref-journal">Stroke</span>
<span class="ref-vol">24</span>, 345–350 [<a href="/pubmed/8446967" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Stroke&amp;title=Aspirin+response+and+failure+in+cerebral+infarction&amp;author=C.+M.+Helgason&amp;author=K.+L.+Tortorice&amp;author=S.+R.+Winkler&amp;author=D.+W.+Penney&amp;author=J.+J.+Schuler&amp;volume=24&amp;publication_year=1993&amp;pages=345-350&amp;pmid=8446967&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B14">14. <span class="mixed-citation">
Patrono C., Rocca B. (2007) <span class="ref-title">Drug insight: aspirin resistance–fact or fashion?</span>
<span class="ref-journal">Nat. Clin. Pract. Cardiovasc. Med</span>. <span class="ref-vol">4</span>, 42–50 [<a href="/pubmed/17180149" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Clin.+Pract.+Cardiovasc.+Med&amp;title=Drug+insight:+aspirin+resistance–fact+or+fashion?&amp;author=C.+Patrono&amp;author=B.+Rocca&amp;volume=4&amp;publication_year=2007&amp;pages=42-50&amp;pmid=17180149&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B15">15. <span class="mixed-citation">
Fitzgerald D. J., Maree A. (2007) <span class="ref-title">Aspirin and clopidogrel resistance</span>. <span class="ref-journal">Hematology Am. Soc. Hematol. Educ. Program</span>
114–120 [<a href="/pubmed/18024618" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hematology+Am.+Soc.+Hematol.+Educ.+Program&amp;title=Aspirin+and+clopidogrel+resistance&amp;author=D.+J.+Fitzgerald&amp;author=A.+Maree&amp;publication_year=2007&amp;pages=114-120&amp;pmid=18024618&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B16">16. <span class="mixed-citation">
Lev E. I. (2009) <span class="ref-title">Aspirin resistance: transient laboratory finding or important clinical entity?</span>
<span class="ref-journal">J. Am. Coll. Cardiol</span>. <span class="ref-vol">53</span>, 678–680 [<a href="/pubmed/19232900" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Am.+Coll.+Cardiol&amp;title=Aspirin+resistance:+transient+laboratory+finding+or+important+clinical+entity?&amp;author=E.+I.+Lev&amp;volume=53&amp;publication_year=2009&amp;pages=678-680&amp;pmid=19232900&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B17">17. <span class="mixed-citation">
Santilli F., Rocca B., De Cristofaro R., Lattanzio S., Pietrangelo L., Habib A., Pettinella C., Recchiuti A., Ferrante E., Ciabattoni G., Davì G., Patrono C. (2009) <span class="ref-title">Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin “resistance”</span>. <span class="ref-journal">J. Am. Coll. Cardiol</span>. <span class="ref-vol">53</span>, 667–677 [<a href="/pubmed/19232899" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Am.+Coll.+Cardiol&amp;title=Platelet+cyclooxygenase+inhibition+by+low-dose+aspirin+is+not+reflected+consistently+by+platelet+function+assays:+implications+for+aspirin+“resistance”&amp;author=F.+Santilli&amp;author=B.+Rocca&amp;author=R.+De+Cristofaro&amp;author=S.+Lattanzio&amp;author=L.+Pietrangelo&amp;volume=53&amp;publication_year=2009&amp;pages=667-677&amp;pmid=19232899&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B18">18. <span class="mixed-citation">
Grosser T., Fries S., Lawson J. A., Kapoor S. C., Grant G. R., Fitzgerald G. A. (2013) <span class="ref-title">Drug resistance and pseudoresistance: an unintended consequence of enteric coating aspirin</span>. <span class="ref-journal">Circulation</span>
<span class="ref-vol">127</span>, 377–385 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3552520/">PMC free article</a>]</span> [<a href="/pubmed/23212718" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Drug+resistance+and+pseudoresistance:+an+unintended+consequence+of+enteric+coating+aspirin&amp;author=T.+Grosser&amp;author=S.+Fries&amp;author=J.+A.+Lawson&amp;author=S.+C.+Kapoor&amp;author=G.+R.+Grant&amp;volume=127&amp;publication_year=2013&amp;pages=377-385&amp;pmid=23212718&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B19">19. <span class="mixed-citation">
Costello P. B., Caruana J. A., Green F. A. (1984) <span class="ref-title">The relative roles of hydrolases of the erythrocyte and other tissues in controlling aspirin survival <em>in vivo</em></span>. <span class="ref-journal">Arthritis Rheum</span>. <span class="ref-vol">27</span>, 422–426 [<a href="/pubmed/6712756" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis+Rheum&amp;title=The+relative+roles+of+hydrolases+of+the+erythrocyte+and+other+tissues+in+controlling+aspirin+survival+in+vivo&amp;author=P.+B.+Costello&amp;author=J.+A.+Caruana&amp;author=F.+A.+Green&amp;volume=27&amp;publication_year=1984&amp;pages=422-426&amp;pmid=6712756&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B20">20. <span class="mixed-citation">
Zhou G., Marathe G. K., Willard B., McIntyre T. M. (2011) <span class="ref-title">Intracellular erythrocyte platelet-activating factor acetylhydrolase inactivates aspirin in blood</span>. <span class="ref-journal">J. Biol. Chem</span>. <span class="ref-vol">286</span>, 34820–34829 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3186390/">PMC free article</a>]</span> [<a href="/pubmed/21844189" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Biol.+Chem&amp;title=Intracellular+erythrocyte+platelet-activating+factor+acetylhydrolase+inactivates+aspirin+in+blood&amp;author=G.+Zhou&amp;author=G.+K.+Marathe&amp;author=B.+Willard&amp;author=T.+M.+McIntyre&amp;volume=286&amp;publication_year=2011&amp;pages=34820-34829&amp;pmid=21844189&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B21">21. <span class="mixed-citation">
Adebayo G. I., Williams J., Healy S. (2007) <span class="ref-title">Aspirin esterase activity–evidence for skewed distribution in healthy volunteers</span>. <span class="ref-journal">Eur. J. Intern. Med</span>. <span class="ref-vol">18</span>, 299–303 [<a href="/pubmed/17574104" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur.+J.+Intern.+Med&amp;title=Aspirin+esterase+activity–evidence+for+skewed+distribution+in+healthy+volunteers&amp;author=G.+I.+Adebayo&amp;author=J.+Williams&amp;author=S.+Healy&amp;volume=18&amp;publication_year=2007&amp;pages=299-303&amp;pmid=17574104&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B22">22. <span class="mixed-citation">
Gresner P., Dolník M., Waczulíková I., Bryszewska M., Sikurová L., Watala C. (2006) <span class="ref-title">Increased blood plasma hydrolysis of acetylsalicylic acid in type 2 diabetic patients: a role of plasma esterases</span>. <span class="ref-journal">Biochim. Biophys. Acta</span>
<span class="ref-vol">1760</span>, 207–215 [<a href="/pubmed/16442234" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochim.+Biophys.+Acta&amp;title=Increased+blood+plasma+hydrolysis+of+acetylsalicylic+acid+in+type+2+diabetic+patients:+a+role+of+plasma+esterases&amp;author=P.+Gresner&amp;author=M.+Dolník&amp;author=I.+Waczulíková&amp;author=M.+Bryszewska&amp;author=L.+Sikurová&amp;volume=1760&amp;publication_year=2006&amp;pages=207-215&amp;pmid=16442234&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B23">23. <span class="mixed-citation">
Kotani K., Kimura S., Ebara T., Caccavello R., Gugliucci A. (2010) <span class="ref-title">Serum aspirin esterase is strongly associated with glucose and lipids in healthy subjects: different association patterns in subjects with type 2 diabetes mellitus</span>. <span class="ref-journal">Diabetol. Metab. Syndr</span>. <span class="ref-vol">2</span>, 50. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2920233/">PMC free article</a>]</span> [<a href="/pubmed/20659351" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diabetol.+Metab.+Syndr&amp;title=Serum+aspirin+esterase+is+strongly+associated+with+glucose+and+lipids+in+healthy+subjects:+different+association+patterns+in+subjects+with+type+2+diabetes+mellitus&amp;author=K.+Kotani&amp;author=S.+Kimura&amp;author=T.+Ebara&amp;author=R.+Caccavello&amp;author=A.+Gugliucci&amp;volume=2&amp;publication_year=2010&amp;pages=50&amp;pmid=20659351&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B24">24. <span class="mixed-citation">
Akopov S. S., Grigorian G. S., Gabrielian E. S. (1992) <span class="ref-title">Dose-dependent aspirin hydrolysis and platelet aggregation in patients with atherosclerosis</span>. <span class="ref-journal">J. Clin. Pharmacol</span>. <span class="ref-vol">32</span>, 133–135 [<a href="/pubmed/1613122" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Clin.+Pharmacol&amp;title=Dose-dependent+aspirin+hydrolysis+and+platelet+aggregation+in+patients+with+atherosclerosis&amp;author=S.+S.+Akopov&amp;author=G.+S.+Grigorian&amp;author=E.+S.+Gabrielian&amp;volume=32&amp;publication_year=1992&amp;pages=133-135&amp;pmid=1613122&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B25">25. <span class="mixed-citation">
Williams F. M., Asad S. I., Lessof M. H., Rawlins M. D. (1987) <span class="ref-title">Plasma esterase activity in patients with aspirin-sensitive asthma or urticaria</span>. <span class="ref-journal">Eur. J. Clin. Pharmacol</span>. <span class="ref-vol">33</span>, 387–390 [<a href="/pubmed/3443144" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur.+J.+Clin.+Pharmacol&amp;title=Plasma+esterase+activity+in+patients+with+aspirin-sensitive+asthma+or+urticaria&amp;author=F.+M.+Williams&amp;author=S.+I.+Asad&amp;author=M.+H.+Lessof&amp;author=M.+D.+Rawlins&amp;volume=33&amp;publication_year=1987&amp;pages=387-390&amp;pmid=3443144&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B26">26. <span class="mixed-citation">
Puche E., Gómez-Valverde E., García Morillas M., Jorde F., Fajardo F., García Gil J. M. (1993) <span class="ref-title">Postoperative decline in plasma aspirin esterase and cholinesterase activity in surgical patients</span>. <span class="ref-journal">Acta Anaesthesiol. Scand</span>. <span class="ref-vol">37</span>, 20–22 [<a href="/pubmed/8424287" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Anaesthesiol.+Scand&amp;title=Postoperative+decline+in+plasma+aspirin+esterase+and+cholinesterase+activity+in+surgical+patients&amp;author=E.+Puche&amp;author=E.+Gómez-Valverde&amp;author=M.+García+Morillas&amp;author=F.+Jorde&amp;author=F.+Fajardo&amp;volume=37&amp;publication_year=1993&amp;pages=20-22&amp;pmid=8424287&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B27">27. <span class="mixed-citation">
Masson P., Froment M. T., Fortier P. L., Visicchio J. E., Bartels C. F., Lockridge O. (1998) <span class="ref-title">Butyrylcholinesterase-catalysed hydrolysis of aspirin, a negatively charged ester, and aspirin-related neutral esters</span>. <span class="ref-journal">Biochim. Biophys. Acta</span>
<span class="ref-vol">1387</span>, 41–52 [<a href="/pubmed/9748494" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochim.+Biophys.+Acta&amp;title=Butyrylcholinesterase-catalysed+hydrolysis+of+aspirin,+a+negatively+charged+ester,+and+aspirin-related+neutral+esters&amp;author=P.+Masson&amp;author=M.+T.+Froment&amp;author=P.+L.+Fortier&amp;author=J.+E.+Visicchio&amp;author=C.+F.+Bartels&amp;volume=1387&amp;publication_year=1998&amp;pages=41-52&amp;pmid=9748494&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B28">28. <span class="mixed-citation">
Santanam N., Parthasarathy S. (2007) <span class="ref-title">Aspirin is a substrate for paraoxonase-like activity: implications in atherosclerosis</span>. <span class="ref-journal">Atherosclerosis</span>
<span class="ref-vol">191</span>, 272–275 [<a href="/pubmed/16793048" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Atherosclerosis&amp;title=Aspirin+is+a+substrate+for+paraoxonase-like+activity:+implications+in+atherosclerosis&amp;author=N.+Santanam&amp;author=S.+Parthasarathy&amp;volume=191&amp;publication_year=2007&amp;pages=272-275&amp;pmid=16793048&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B29">29. <span class="mixed-citation">
Harel M., Aharoni A., Gaidukov L., Brumshtein B., Khersonsky O., Meged R., Dvir H., Ravelli R. B., McCarthy A., Toker L., Silman I., Sussman J. L., Tawfik D. S. (2004) <span class="ref-title">Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes</span>. <span class="ref-journal">Nat. Struct. Mol. Biol</span>. <span class="ref-vol">11</span>, 412–419 [<a href="/pubmed/15098021" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Struct.+Mol.+Biol&amp;title=Structure+and+evolution+of+the+serum+paraoxonase+family+of+detoxifying+and+anti-atherosclerotic+enzymes&amp;author=M.+Harel&amp;author=A.+Aharoni&amp;author=L.+Gaidukov&amp;author=B.+Brumshtein&amp;author=O.+Khersonsky&amp;volume=11&amp;publication_year=2004&amp;pages=412-419&amp;pmid=15098021&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B30">30. <span class="mixed-citation">
Aharoni A., Gaidukov L., Yagur S., Toker L., Silman I., Tawfik D. S. (2004) <span class="ref-title">Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization</span>. <span class="ref-journal">Proc. Natl. Acad. Sci. U.S.A</span>. <span class="ref-vol">101</span>, 482–487 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC327173/">PMC free article</a>]</span> [<a href="/pubmed/14695884" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+U.S.A&amp;title=Directed+evolution+of+mammalian+paraoxonases+PON1+and+PON3+for+bacterial+expression+and+catalytic+specialization&amp;author=A.+Aharoni&amp;author=L.+Gaidukov&amp;author=S.+Yagur&amp;author=L.+Toker&amp;author=I.+Silman&amp;volume=101&amp;publication_year=2004&amp;pages=482-487&amp;pmid=14695884&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B31">31. <span class="mixed-citation">
Ellman G. L. (1959) <span class="ref-title">Tissue sulfhydryl groups</span>. <span class="ref-journal">Arch Biochem. Biophys</span>. <span class="ref-vol">82</span>, 70–77 [<a href="/pubmed/13650640" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch+Biochem.+Biophys&amp;title=Tissue+sulfhydryl+groups&amp;author=G.+L.+Ellman&amp;volume=82&amp;publication_year=1959&amp;pages=70-77&amp;pmid=13650640&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B32">32. <span class="mixed-citation">
Kuo C. L., La Du B. N. (1995) <span class="ref-title">Comparison of purified human and rabbit serum paraoxonases</span>. <span class="ref-journal">Drug Metab. Dispos</span>. <span class="ref-vol">23</span>, 935–944 [<a href="/pubmed/8565784" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drug+Metab.+Dispos&amp;title=Comparison+of+purified+human+and+rabbit+serum+paraoxonases&amp;author=C.+L.+Kuo&amp;author=B.+N.+La+Du&amp;volume=23&amp;publication_year=1995&amp;pages=935-944&amp;pmid=8565784&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B33">33. <span class="mixed-citation">
Bhattacharyya T., Nicholls S. J., Topol E. J., Zhang R., Yang X., Schmitt D., Fu X., Shao M., Brennan D. M., Ellis S. G., Brennan M. L., Allayee H., Lusis A. J., Hazen S. L. (2008) <span class="ref-title">Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk</span>. <span class="ref-journal">JAMA</span>
<span class="ref-vol">299</span>, 1265–1276 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3014051/">PMC free article</a>]</span> [<a href="/pubmed/18349088" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Relationship+of+paraoxonase+1+(PON1)+gene+polymorphisms+and+functional+activity+with+systemic+oxidative+stress+and+cardiovascular+risk&amp;author=T.+Bhattacharyya&amp;author=S.+J.+Nicholls&amp;author=E.+J.+Topol&amp;author=R.+Zhang&amp;author=X.+Yang&amp;volume=299&amp;publication_year=2008&amp;pages=1265-1276&amp;pmid=18349088&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B34">34. <span class="mixed-citation">
Hartiala J., Li D., Conti D. V., Vikman S., Patel Y., Tang W. H., Brennan M. L., Newman J. W., Stephensen C. B., Armstrong P., Hazen S. L., Allayee H. (2011) <span class="ref-title">Genetic contribution of the leukotriene pathway to coronary artery disease</span>. <span class="ref-journal">Hum. Genet</span>. <span class="ref-vol">129</span>, 617–627 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3092945/">PMC free article</a>]</span> [<a href="/pubmed/21293878" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum.+Genet&amp;title=Genetic+contribution+of+the+leukotriene+pathway+to+coronary+artery+disease&amp;author=J.+Hartiala&amp;author=D.+Li&amp;author=D.+V.+Conti&amp;author=S.+Vikman&amp;author=Y.+Patel&amp;volume=129&amp;publication_year=2011&amp;pages=617-627&amp;pmid=21293878&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B35">35. <span class="mixed-citation">
Wang Z., Klipfell E., Bennett B. J., Koeth R., Levison B. S., Dugar B., Feldstein A. E., Britt E. B., Fu X., Chung Y. M., Wu Y., Schauer P., Smith J. D., Allayee H., Tang W. H., DiDonato J. A., Lusis A. J., Hazen S. L. (2011) <span class="ref-title">Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease</span>. <span class="ref-journal">Nature</span>
<span class="ref-vol">472</span>, 57–63 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3086762/">PMC free article</a>]</span> [<a href="/pubmed/21475195" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Gut+flora+metabolism+of+phosphatidylcholine+promotes+cardiovascular+disease&amp;author=Z.+Wang&amp;author=E.+Klipfell&amp;author=B.+J.+Bennett&amp;author=R.+Koeth&amp;author=B.+S.+Levison&amp;volume=472&amp;publication_year=2011&amp;pages=57-63&amp;pmid=21475195&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B36">36. <span class="mixed-citation">
Tang W. H., Wu Y., Hartiala J., Fan Y., Stewart A. F., Roberts R., McPherson R., Fox P. L., Allayee H., Hazen S. L. (2012) <span class="ref-title">Clinical and genetic association of serum ceruloplasmin with cardiovascular risk</span>. <span class="ref-journal">Arterioscler. Thromb. Vasc. Biol</span>. <span class="ref-vol">32</span>, 516–522 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3262121/">PMC free article</a>]</span> [<a href="/pubmed/22075249" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arterioscler.+Thromb.+Vasc.+Biol&amp;title=Clinical+and+genetic+association+of+serum+ceruloplasmin+with+cardiovascular+risk&amp;author=W.+H.+Tang&amp;author=Y.+Wu&amp;author=J.+Hartiala&amp;author=Y.+Fan&amp;author=A.+F.+Stewart&amp;volume=32&amp;publication_year=2012&amp;pages=516-522&amp;pmid=22075249&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B37">37. <span class="mixed-citation">
Soliday F. K., Conley Y. P., Henker R. (2010) <span class="ref-title">Pseudocholinesterase deficiency: a comprehensive review of genetic, acquired, and drug influences</span>. <span class="ref-journal">AANA J</span>. <span class="ref-vol">78</span>, 313–320 [<a href="/pubmed/20879632" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=AANA+J&amp;title=Pseudocholinesterase+deficiency:+a+comprehensive+review+of+genetic,+acquired,+and+drug+influences&amp;author=F.+K.+Soliday&amp;author=Y.+P.+Conley&amp;author=R.+Henker&amp;volume=78&amp;publication_year=2010&amp;pages=313-320&amp;pmid=20879632&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B38">38. <span class="mixed-citation">
Nogueira C. P., McGuire M. C., Graeser C., Bartels C. F., Arpagaus M., Van der Spek A. F., Lightstone H., Lockridge O., La Du B. N. (1990) <span class="ref-title">Identification of a frameshift mutation responsible for the silent phenotype of human serum cholinesterase, Gly 117 (GGT—-GGAG)</span>. <span class="ref-journal">Am. J. Hum. Genet</span>. <span class="ref-vol">46</span>, 934–942 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1683584/">PMC free article</a>]</span> [<a href="/pubmed/2339692" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am.+J.+Hum.+Genet&amp;title=Identification+of+a+frameshift+mutation+responsible+for+the+silent+phenotype+of+human+serum+cholinesterase,+Gly+117+(GGT—-GGAG)&amp;author=C.+P.+Nogueira&amp;author=M.+C.+McGuire&amp;author=C.+Graeser&amp;author=C.+F.+Bartels&amp;author=M.+Arpagaus&amp;volume=46&amp;publication_year=1990&amp;pages=934-942&amp;pmid=2339692&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B39">39. <span class="mixed-citation">
Bouman H. J., Schömig E., van Werkum J. W., Velder J., Hackeng C. M., Hirschhäuser C., Waldmann C., Schmalz H. G., ten Berg J. M., Taubert D. (2011) <span class="ref-title">Paraoxonase-1 is a major determinant of clopidogrel efficacy</span>. <span class="ref-journal">Nat. Med</span>. <span class="ref-vol">17</span>, 110–116 [<a href="/pubmed/21170047" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Med&amp;title=Paraoxonase-1+is+a+major+determinant+of+clopidogrel+efficacy&amp;author=H.+J.+Bouman&amp;author=E.+Schömig&amp;author=J.+W.+van+Werkum&amp;author=J.+Velder&amp;author=C.+M.+Hackeng&amp;volume=17&amp;publication_year=2011&amp;pages=110-116&amp;pmid=21170047&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B40">40. <span class="mixed-citation">
Ho Y. S., Swenson L., Derewenda U., Serre L., Wei Y., Dauter Z., Hattori M., Adachi T., Aoki J., Arai H., Inoue K., Derewenda Z. S. (1997) <span class="ref-title">Brain acetylhydrolase that inactivates platelet-activating factor is a G-protein-like trimer</span>. <span class="ref-journal">Nature</span>
<span class="ref-vol">385</span>, 89–93 [<a href="/pubmed/8985254" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Brain+acetylhydrolase+that+inactivates+platelet-activating+factor+is+a+G-protein-like+trimer&amp;author=Y.+S.+Ho&amp;author=L.+Swenson&amp;author=U.+Derewenda&amp;author=L.+Serre&amp;author=Y.+Wei&amp;volume=385&amp;publication_year=1997&amp;pages=89-93&amp;pmid=8985254&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B41">41. <span class="mixed-citation">
Jack D. B. (1997) <span class="ref-title">One hundred years of aspirin</span>. <span class="ref-journal">Lancet</span>
<span class="ref-vol">350</span>, 437–439 [<a href="/pubmed/9259670" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=One+hundred+years+of+aspirin&amp;author=D.+B.+Jack&amp;volume=350&amp;publication_year=1997&amp;pages=437-439&amp;pmid=9259670&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B42">42. <span class="mixed-citation">
Coma-Canella I., Velasco A., Castano S. (2005) <span class="ref-title">Prevalence of aspirin resistance measured by PFA-100</span>. <span class="ref-journal">Int. J. Cardiol</span>. <span class="ref-vol">101</span>, 71–76 [<a href="/pubmed/15860386" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int.+J.+Cardiol&amp;title=Prevalence+of+aspirin+resistance+measured+by+PFA-100&amp;author=I.+Coma-Canella&amp;author=A.+Velasco&amp;author=S.+Castano&amp;volume=101&amp;publication_year=2005&amp;pages=71-76&amp;pmid=15860386&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B43">43. <span class="mixed-citation">
Pedersen A. K., FitzGerald G. A. (1984) <span class="ref-title">Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase</span>. <span class="ref-journal">N. Engl. J. Med</span>. <span class="ref-vol">311</span>, 1206–1211 [<a href="/pubmed/6436696" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N.+Engl.+J.+Med&amp;title=Dose-related+kinetics+of+aspirin.+Presystemic+acetylation+of+platelet+cyclooxygenase&amp;author=A.+K.+Pedersen&amp;author=G.+A.+FitzGerald&amp;volume=311&amp;publication_year=1984&amp;pages=1206-1211&amp;pmid=6436696&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B44">44. <span class="mixed-citation">
Simeon-Rudolf V., Reiner E., Evans R. T., George P. M., Potter H. C. (1999) <span class="ref-title">Catalytic parameters for the hydrolysis of butyrylthiocholine by human serum butyrylcholinesterase variants</span>. <span class="ref-journal">Chem. Biol. Interact</span>. <span class="ref-vol">119–120</span>, 165–171 [<a href="/pubmed/10421450" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chem.+Biol.+Interact&amp;title=Catalytic+parameters+for+the+hydrolysis+of+butyrylthiocholine+by+human+serum+butyrylcholinesterase+variants&amp;author=V.+Simeon-Rudolf&amp;author=E.+Reiner&amp;author=R.+T.+Evans&amp;author=P.+M.+George&amp;author=H.+C.+Potter&amp;volume=119–120&amp;publication_year=1999&amp;pages=165-171&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B45">45. <span class="mixed-citation">
Goodall R. (2004) <span class="ref-title">Cholinesterase: phenotyping and genotyping</span>. <span class="ref-journal">Ann. Clin. Biochem</span>. <span class="ref-vol">41</span>, 98–110 [<a href="/pubmed/15025799" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann.+Clin.+Biochem&amp;title=Cholinesterase:+phenotyping+and+genotyping&amp;author=R.+Goodall&amp;volume=41&amp;publication_year=2004&amp;pages=98-110&amp;pmid=15025799&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B46">46. <span class="mixed-citation">
Manya H., Aoki J., Watanabe M., Adachi T., Asou H., Inoue Y., Arai H., Inoue K. (1998) <span class="ref-title">Switching of platelet-activating factor acetylhydrolase catalytic subunits in developing rat brain</span>. <span class="ref-journal">J. Biol. Chem</span>. <span class="ref-vol">273</span>, 18567–18572 [<a href="/pubmed/9660828" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Biol.+Chem&amp;title=Switching+of+platelet-activating+factor+acetylhydrolase+catalytic+subunits+in+developing+rat+brain&amp;author=H.+Manya&amp;author=J.+Aoki&amp;author=M.+Watanabe&amp;author=T.+Adachi&amp;author=H.+Asou&amp;volume=273&amp;publication_year=1998&amp;pages=18567-18572&amp;pmid=9660828&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B47">47. <span class="mixed-citation">
Manya H., Aoki J., Kato H., Ishii J., Hino S., Arai H., Inoue K. (1999) <span class="ref-title">Biochemical characterization of various catalytic complexes of the brain platelet-activating factor acetylhydrolase</span>. <span class="ref-journal">J. Biol. Chem</span>. <span class="ref-vol">274</span>, 31827–31832 [<a href="/pubmed/10542206" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Biol.+Chem&amp;title=Biochemical+characterization+of+various+catalytic+complexes+of+the+brain+platelet-activating+factor+acetylhydrolase&amp;author=H.+Manya&amp;author=J.+Aoki&amp;author=H.+Kato&amp;author=J.+Ishii&amp;author=S.+Hino&amp;volume=274&amp;publication_year=1999&amp;pages=31827-31832&amp;pmid=10542206&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B48">48. <span class="mixed-citation">
Koizumi H., Yamaguchi N., Hattori M., Ishikawa T. O., Aoki J., Taketo M. M., Inoue K., Arai H. (2003) <span class="ref-title">Targeted disruption of intracellular type I platelet-activating factor acetylhydrolase catalytic subunits causes severe impairment in spermatogenesis</span>. <span class="ref-journal">J. Biol. Chem</span>. <span class="ref-vol">278</span>, 12489–12494 [<a href="/pubmed/12551946" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.+Biol.+Chem&amp;title=Targeted+disruption+of+intracellular+type+I+platelet-activating+factor+acetylhydrolase+catalytic+subunits+causes+severe+impairment+in+spermatogenesis&amp;author=H.+Koizumi&amp;author=N.+Yamaguchi&amp;author=M.+Hattori&amp;author=T.+O.+Ishikawa&amp;author=J.+Aoki&amp;volume=278&amp;publication_year=2003&amp;pages=12489-12494&amp;pmid=12551946&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3636881&amp;issue-id=222308&amp;journal-id=567&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#idm139867451761280title">Abstract</a></li><li><a href="#__sec1title">Introduction</a></li><li><a href="#__sec2title">EXPERIMENTAL PROCEDURES</a></li><li><a href="#__sec14title">RESULTS</a></li><li><a href="#__sec22title">DISCUSSION</a></li><li><a href="#idm139867444832688title">Acknowledgments</a></li><li><a href="#idm139867442044368title">REFERENCES</a></li></ul></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr>Articles from <span class="acknowledgment-journal-title">The Journal of Biological Chemistry</span> are provided here courtesy of <strong>American Society for Biochemistry and Molecular Biology</strong></div></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC3636881/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC3636881/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC3636881/pdf/zbc11940.pdf">PDF (1.5M)</a></li> | <li><a href="#" data-citationid="PMC3636881" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3636881%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3636881%2F&amp;text=Aspirin%20Hydrolysis%20in%20Plasma%20Is%20a%20Variable%20Function%20of%20Butyrylcholinesterase%20and%20Platelet-activating%20Factor%20Acetylhydrolase%201b2%20(PAFAH1b2)" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3636881%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="23508960" data-aiid="3636881" data-aid="3636881" data-iid="222308" data-domainid="567" data-domain="jbc" data-accid="PMC3636881" data-md5="78d671ae1194e85757a2360fe2046142"><img src="/portal/portal3rc.fcgi/4018218/img/3631476" alt="Loading..." align="absmiddle"> Loading portlets...</div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T10:29:49-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal101&amp;ncbi_phid=CE888A1DDD5561410000000004AC0313&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3636881%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=jbc&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC3636881/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>